WE ARE CREATING THE FUTURE OF HEALTH
DISPENDIX provides premium liquid handling technology to scientists and lab technicians around the world, and is creating the future of medicine. Liquid handling technology enables new discoveries in areas such as drug development, diagnostics and synthetic biology. We believe that technological advances and science are made for each other. Good technology simplifies science. DISPENDIX GmbH, the premier provider of noncontact liquid handling solutions in the nano to microliter range, started out in 2016 as a spin-off from the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany. In 2018, DISPENDIX joined the world’s leading bio convergence company BICO, which now encompasses 900+ colleagues and 11 companies, offering a portfolio of technologies, products and services to create the future of health. Part of that portfolio is DISPENDIX’s award winning patented and widely recognized technology, the I.DOT (Immediate Drop-on-demand Technology), which brings intuitive automation, precision and speed to every lab, allowing scientists to optimize liquid handling workflows and accelerate their research in a range of applications.

Life Sciences

Biotechnology

Medical Devices

DISPENDIX

Petros Apostolopoulos

Thomas Rawlins

Matt Morrison

Edmund Yap

Dr. Stefan Borja Bammesberger

Engineering Team

Leadership Team

Sales and Marketing

��

DISPENDIX

Org chart

Teams

Engineering Team

Leadership Team

Sales and Marketing

Similar companies

��������

DISPENDIX

Org chart

Teams

Engineering Team

Leadership Team

Sales and Marketing

Similar companies

��